Patient Guide: UNITI-2: Phase 3 randomized, double-blind, placebo-controlled intravenous induction study of ustekinumab in adults with moderately to severely active Crohn's disease (CDAI 220-450).

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT01369342
Status: COMPLETED
Condition: Crohn's disease
Phase: PHASE3

Loading interactive enrollment tools...

The full interactive experience will load momentarily